• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用国际浆膜腔液细胞病理学报告系统对浆膜腔积液进行分类,并评估诊断准确性的恶性肿瘤风险。

Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.

机构信息

Department of Pathology, Shri Guru Ram Rai Institute of Medical and Health Sciences, Dehradun, Uttrakhand, India.

出版信息

Cytopathology. 2022 Mar;33(2):176-184. doi: 10.1111/cyt.13089. Epub 2021 Dec 28.

DOI:10.1111/cyt.13089
PMID:34913541
Abstract

CONTEXT

The International System for Reporting Serous Fluid Cytopathology (ISRSFC) standardises the reporting of serous effusion cytology under five categories: Non-Diagnostic (ND), Negative for Malignancy (NFM), Atypia of Undetermined Significance (AUS), Suspicious for Malignancy (SFM), and Malignant (M). Very few studies have been conducted so far to confirm the risk of malignancy of the different categories.

AIMS

The main objectives of our study were to classify serous effusions according to the ISRSFC categories and assess their risk of malignancy (ROM) and performance parameters.

MATERIALS AND METHODS

All serous effusion samples received from January 2019 to December 2020 were reclassified according to the ISRSFC. Using histopathological diagnosis as the gold standard, ROM and performance parameters were calculated.

RESULTS

A total of 831 pleural effusion samples were reclassified as follows: ND, 3 (0.4%); NFM, 635 (76.4%); AUS, 65 (7.8%); SFM, 60 (7.2%); and M, 68 (8.2%). For 457 peritoneal effusion samples, the reclassifications were ND, 5 (1.1%); NFM, 368 (80.5%); AUS, 19 (4.2%); SFM, 17 (3.7%); and M, 48 (10.5%). All 12 (100%) pericardial effusions belonged to the NFM category. The ROM for the ND, NFM, AUS, SRM, and M categories was 0%, 2.1%, 33.3%, 94.1%, 100%, respectively, in pleural effusions, and 50%, 4.8%, 22.2%, 83.3%, 100%, respectively, in peritoneal effusions. The ROM was 0% for NFM in pericardial effusions.

CONCLUSION

The ISRSFC is an excellent system for accurately classifying serous effusions with greater reproducibility of reports and better communication between pathologist and clinician.

摘要

背景

国际浆膜腔液细胞学报告系统(ISRSFC)将浆膜腔液细胞学报告标准化为五个类别:非诊断性(ND)、非恶性(NFM)、意义未明的非典型性(AUS)、疑似恶性(SFM)和恶性(M)。迄今为止,很少有研究证实不同类别浆膜腔液的恶性风险。

目的

本研究的主要目的是根据 ISRSFC 对浆膜腔液进行分类,并评估其恶性风险(ROM)和性能参数。

材料和方法

对 2019 年 1 月至 2020 年 12 月期间收到的所有浆膜腔液样本进行重新分类,根据 ISRSFC 进行分类。使用组织病理学诊断作为金标准,计算 ROM 和性能参数。

结果

共对 831 例胸腔积液样本进行了重新分类:ND,3 例(0.4%);NFM,635 例(76.4%);AUS,65 例(7.8%);SFM,60 例(7.2%);M,68 例(8.2%)。对于 457 例腹腔积液样本,重新分类为 ND,5 例(1.1%);NFM,368 例(80.5%);AUS,19 例(4.2%);SFM,17 例(3.7%);M,48 例(10.5%)。所有 12 例(100%)心包积液均属于 NFM 类别。在胸腔积液中,ND、NFM、AUS、SFM 和 M 类别的 ROM 分别为 0%、2.1%、33.3%、94.1%和 100%,在腹腔积液中,ROM 分别为 50%、4.8%、22.2%、83.3%和 100%。在心包积液中,NFM 的 ROM 为 0%。

结论

ISRSFC 是一种出色的浆膜腔液分类系统,具有更高的报告重复性和病理学家与临床医生之间更好的沟通能力。

相似文献

1
Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.使用国际浆膜腔液细胞病理学报告系统对浆膜腔积液进行分类,并评估诊断准确性的恶性肿瘤风险。
Cytopathology. 2022 Mar;33(2):176-184. doi: 10.1111/cyt.13089. Epub 2021 Dec 28.
2
Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.浆膜腔积液的细胞组织学相关性应用新提出的国际浆膜腔液细胞病理学报告系统:肿瘤中心的经验。
Diagn Cytopathol. 2021 May;49(5):596-605. doi: 10.1002/dc.24440. Epub 2020 Apr 27.
3
Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.国际浆膜腔液细胞病理学报告系统(TIS)的应用:一项回顾性机构研究。
Cytopathology. 2022 May;33(3):305-311. doi: 10.1111/cyt.13113. Epub 2022 Mar 7.
4
Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.国际浆膜腔液细胞学报告系统(ISRSFC)在积液标本中的应用——一项肿瘤学环境中的前瞻性研究。
J Am Soc Cytopathol. 2023 Sep-Oct;12(5):351-361. doi: 10.1016/j.jasc.2023.04.005. Epub 2023 May 3.
5
A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.回顾性分析新提出的国际浆膜腔液细胞病理学报告系统在浆膜腔积液标本中的应用:机构经验。
Acta Cytol. 2023;67(1):70-79. doi: 10.1159/000527398. Epub 2022 Dec 7.
6
Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: A retrospective study.国际浆膜腔液细胞病理报告系统(ISRSFC)在浆膜腔积液报告中的应用:一项回顾性研究。
Medicine (Baltimore). 2023 Oct 27;102(43):e35707. doi: 10.1097/MD.0000000000035707.
7
Risk of malignancy assessment of the International System for Reporting Serous Fluid Cytopathology: Experience in a community hospital setting and comparison with other studies.国际浆液性液体细胞病理学报告系统的恶性肿瘤风险评估:社区医院环境中的经验及与其他研究的比较。
Cancer Cytopathol. 2022 Dec;130(12):964-973. doi: 10.1002/cncy.22638. Epub 2022 Aug 22.
8
Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.国际浆膜腔液细胞病理学报告系统在心包液中的应用:不明确诊断的根本原因分析、细胞组织学相关性及恶性风险评估。
Cancer Cytopathol. 2023 Jul;131(7):433-441. doi: 10.1002/cncy.22696. Epub 2023 Mar 27.
9
Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.国际浆膜腔液细胞病理学报告系统对不同浆膜腔积液良恶性病因的综合评估:台湾的一项多机构研究。
Cancer Cytopathol. 2024 Mar;132(3):169-178. doi: 10.1002/cncy.22783. Epub 2023 Dec 8.
10
Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.国际浆膜液细胞病理学报告系统(ISRSFC)在心包积液细胞学报告中的应用。
Acta Cytol. 2020;64(5):477-485. doi: 10.1159/000507311. Epub 2020 May 18.

引用本文的文献

1
The International System for Reporting Serous Fluid Cytopathology-An Updated Review.国际浆液性液体细胞病理学报告系统——最新综述
J Clin Transl Pathol. 2023;3(4):160-177. doi: 10.14218/jctp.2023.00025. Epub 2023 Dec 20.
2
Deciphering Serous Effusions Using the New International System for Reporting Serous Fluid Cytopathology.使用新的国际浆液性液体细胞病理学报告系统解读浆液性积液
Cureus. 2024 May 10;16(5):e60042. doi: 10.7759/cureus.60042. eCollection 2024 May.